Angina pectoris


Cardiovascular disease in general remains the number one cause of death and disability around the globe

Much has been learned in the second half of the 20th century on underlying risk factors and strategies for cardiovascular disease prevention that may assist countries in Asia, Africa, the Middle East, and Eastern Europe in developing their own effective prevention and management strategies.

Many factors should be taken into consideration:  the ageing population, accelerated changes in lifestyle and economic development.

Chronic Coronary Syndromes  (CCS) and Angina pectoris in particular remain a major burden on a global scale.

However, considerable progress in the understanding of Chronic Coronary Syndromes has been achieved. This progress in the perception of CCS as a multifactorial disease has contributed to a decline in mortality for acute events.
In order to better equip physicians worldwide, a  great number of guidelines have been issued in recent years, for example by the European Society of Cardiology (ESC), as well as by other societies and organisations. The new guidelines recognise that chronic coronary disease may have many different facets and is a dynamic process of plaque accumulation and functional changes of coronary circulation that can be modified by lifestyle changes, pharmacological therapies and revascularisation.


Even though Guidelines have been presented in major conferences, implementation programmes at regional and national level are needed to promote a thorough application of clinical recommendations since many patients still progress to develop ischaemic heart failure.

Therefore the board of TMA has decided to create an online education platform to meet the educational gaps with a problem-based approach.

The objectives of the Angina updates platform are:


  • Provide an update on diagnosis, risk factors and pharmacological treatments of Angina Pectoris, including the benefits of early interventions
  • Review latest guidelines and their implementation at individual and teams levels
  • Share information about lifestyle modifications
  • Discuss regional differences and share best practices
  • Develop problem-based skills to improve patients’ outcomes


Access digital platform



  • Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407-477.
  • Jeffery RA, To MJ, Hayduk-Costa G, et al. Interventions to improve adherence to cardiovascular disease guidelines: a systematic review. BMC Fam Pract 2015;16:147.
  • Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317–22.
  • Feifer C, Ornstein SM, Jenkins RG, Wessell A, Corley ST, Nemeth LS, et al. The logic behind a multimethod intervention to improve adherence to clinical practice guidelines in a nationwide network of primary care practices. Eval Health Prof 2006;29:65–88.
  • Davis DA, Taylor-Vaisey A. Translating guidelines into practice. Can Med Assoc J 1997;157:408–16.
  • He T, Liu X, Xu N, Li Y, Wu Q, Liu M, Yuan H. Diagnostic models of the pre-test probability of stable coronary artery disease: A systematic review. Clinics (Sao Paulo). 2017;72(3):188-196.
  • Smith SC Jr, Benjamin EJ, Bonow RO, et al, for the AHA/ACCF, World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;24(22):2458-73.
  • Mach F, Baigent C, Catapano A, et al.; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019; ehz455.